News Qiagen N.V. Deutsche Boerse AG

Equities

QIA

NL0015001WM6

Market Closed - Deutsche Boerse AG Other stock markets 09:17:41 24/05/2024 BST			5-day change	1st Jan Change
40.23 ^EUR	+0.05%		-4.21%	-0.73%

05-21	QIAGEN NV : Berenberg maintains a Buy rating	ZD
05-15	Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN NV : Berenberg maintains a Buy rating	05-21	ZD
Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	05-15	MT
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	05-14	AQ
QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret	05-14	CI
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	05-13	PU
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test	05-13	MT
Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel	05-13	MT
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	05-13	AQ
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	05-08	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	05-08	PU
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics	05-08	MT
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	05-07	AQ
QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics	05-07	CI
Qiagen N : Q1 2024 Results Investor Introduction	05-03	PU
Qiagen N : Virtual Berenberg MDx Day Investor Introduction	05-02	PU
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	05-02	AQ
QIAGEN Announces the Availability of QCI Secondary Analysis	05-02	CI
Qiagen N : First Quarter 2024 SEC Filing	05-02	PU
QIAGEN NV : Berenberg reaffirms its Buy rating	04-30	ZD
QIAGEN : A decent start to 2024; guidance unchanged	04-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 02:32 pm